By: Anton Bespalov

Ten years later: Are we there yet?
December 24, 2025

PAASP was founded in November 2015 to provide services related to rigor in nonregulated biomedical research – with a mission to…

Read More
EQIPD / PAASP Newsletter December 2025
December 24, 2025

The current issue of our newsletter is special as this is issue no. 50 and it marks the 10th anniversary of PAASP! Today we share with…

Read More
Questionable data in neurodegeneration research: A coincidence?
December 23, 2025

If you have not read the book “Doctored” by Charles Piller (here), you may want to have a look at the…

Read More
Quality management initiatives: Economic perspective
December 19, 2025

In July 2025, the U.S. FDA published a white paper on how strategic investments in quality management initiatives in the pharmaceutical…

Read More
Assessment of benefit of animal research
December 19, 2025

Unless and until we have validated non-animal alternative methods available for routine use, the involvement of animals in research is required…

Read More
Valuable resource: Sex as a biological variable
December 19, 2025

Several years ago, we were part of an NIH-funded consortium that developed training materials to provide practical guidance to preclinical researchers…

Read More
Good Research Practice: Why not?
December 18, 2025

This is indeed the central theme of the current newsletter and this has been the central theme in our discussions with…

Read More
To ARRIVE or not: Ticking (wrong) boxes
December 17, 2025

Every now and then we read publications stating that experiments “were conducted according to ARRIVE guidelines”. In most cases, such statements suggest that…

Read More
The roots of education are bitter, but the fruit is sweet
December 9, 2025

Thus spoke Aristotle … and so did we when launching the online course on Good Research Practice in summer 2025 that…

Read More
PAASP is now on Mastodon!
March 20, 2025

We’re excited to join the Mastodon community. Follow us to explore and discuss topics around research reproducibility, preclinical quality, and translational science. We’ll share…

Read More